Basio, Jonathan .
HRN: 23-52-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/11/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/11/2023
08/17/2023
IV
1.5 Grams IV
Q6
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes